WST P/E Ratio
P/E Ratio as of Jul 9, 2025: 35.52
Average34.77
Median34.78
Minimum33.89
Maximum35.76
35.52
Past Month+0.24 (0.68%)
The P/E ratio for WST is 35.52 as of Jul 9, 2025. This represents a decrease of -13.05% compared to its 12-month average P/E ratio of 40.85. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
West Pharmaceutical Services P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
West Pharmaceutical Services’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing West Pharmaceutical Services to industry peers.
West Pharmaceutical Services P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
West Pharmaceutical Services’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing West Pharmaceutical Services to industry peers.
WST P/E Ratio Insights
See West Pharmaceutical Services’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in WST
Order type
Buy in
Order amount
Est. shares
0 shares
WST P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $222.42 | 34.93 |
| Jun 2, 2025 | $209.39 | 32.88 |
| May 1, 2025 | $210.26 | 33.02 |
| Apr 1, 2025 | $220.16 | 32.91 |
| Mar 3, 2025 | $228.05 | 34.09 |
| Feb 3, 2025 | $337.03 | 49.99 |
| Jan 2, 2025 | $328.39 | 48.71 |
WST End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 35.52 | -26.90% |
| 2024 | 48.59 | +2.27% |
| 2023 | 47.51 | +67.52% |
| 2022 | 28.36 | -47.32% |
| 2021 | 53.83 | -13.15% |
| 2020 | 61.98 | — |
FAQs About West Pharmaceutical Services (WST) P/E ratio
The latest P/E ratio of WST is 35.52, as of Jul 9, 2025. This is calculated based on its current stock price and earnings per share (EPS).
West Pharmaceutical Services’s last 12-month average P/E ratio is 40.85, compared to its current P/E ratio of 35.52. This reflects a decrease of -13.05%.
West Pharmaceutical Services’s current P/E ratio of 35.52 is lower than its last 12-month average P/E of 40.85. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
West Pharmaceutical Services’s average P/E ratio over the last 3 years is 42.7. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
West Pharmaceutical Services’s average P/E ratio over the last 5 years is 47.89. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.